Global Genotyping Assay Market to 2023: Growing Importance of Sequencing Projects, Increasing Application Areas of Genotyping & Increasing Demand for Genome Analysis in Plant and Animal Livestock

News provided by

Nov 28, 2018, 09:30 ET

DUBLIN, Nov. 28, 2018 /PRNewswire/ --

The "Genotyping Assay Market by Technology (PCR, Sequencing, Microarray, Electrophoresis, MALDI-TOF), Application (Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology), and Product - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

The genotyping market is expected to reach USD 31.9 billion by 2023 from an estimated USD 11.8 billion in 2018, at a CAGR of 22.0%

Technological advancements, the decreasing prices of DNA sequencing, and the increasing incidence of genetic diseases are expected to drive the growth of the global genotyping market. However, the high cost of equipment is expected to restrain market growth to a certain extent during the forecast period.

Pharmacogenomics application segment to witness the highest growth during the forecast period.

On the basis of application, the genotyping market is segmented into pharmacogenomics, diagnostic & personalized medicine, agricultural biotechnology, animal genetics, and other applications. The pharmacogenomics segment is expected to register the highest CAGR during the forecast period. The increased use of genotyping to predict the efficiency of drugs during drug development and the growing need to understand the adverse effects of drugs are the major factors driving the growth of this market segment.

Pharmaceutical and biopharmaceutical companies end-user segment is expected to grow at the highest CAGR during the forecast period.

On the basis of end user, the genotyping market is segmented into pharmaceutical & biopharmaceutical companies, diagnostic & research institutes, academic institutes, and other end users. The pharmaceutical & biopharmaceutical companies segment is expected to witness the highest CAGR owing to the growing importance of biomarkers in genotyping used among these end users, given their applications in drug development which, in turn, will support the growth of this segment.

APAC is projected to witness the highest growth during the forecast period.

North America is expected to account for the largest share of the global genotyping market in 2018. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to the increasing incidence of chronic diseases and growing awareness on the use of genotyping tests to control the inheritance of genetic diseases & the spread of infectious and microbial diseases in APAC countries.

The increasing outsourcing of clinical research and trials by pharmaceutical and biopharmaceutical companies to organizations in the APAC has driven the demand for genotyping products for drug profile assessment, drug efficacy, safety assessment, dosing determination, and drug response evaluation.

Key Topics Covered:

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Genotyping Market Overview
4.2 Asia Pacific: Genotyping Market, By Product & Service, By Country, 2017
4.3 Geographic Snapshot of the Genotyping Market
4.4 Geographic Mix: Genotyping Market
4.5 Genotyping Market: Developing vs Developed Markets

5 Market Overview
5.1 Introduction
5.2 Market Dynamics: Impact Analysis
5.3 Market Drivers
5.3.1 Technological Advancements and Decreasing Prices of Dna Sequencing
5.3.2 Increasing Incidence of Genetic Diseases and Rising Awareness on Personalized Medicine
5.3.3 Growing Importance of Genotyping in Drug Development
5.3.4 Increasing Demand for Bioinformatics Solutions in Data Analysis
5.4 Market Restraints
5.4.1 High Cost of Equipment Used in Genotyping
5.5 Market Opportunities
5.5.1 Growing Importance of Sequencing Projects
5.5.2 Increasing Application Areas of Genotyping
5.5.3 Increasing Demand for Genome Analysis in Plant and Animal Livestock
5.6 Market Challenges
5.6.1 Data Management in Genotyping Research
5.6.2 Dearth of Trained Resources

6 Industry Insights
6.1 Industry Trends
6.1.1 Increasing Demand for Genotyping & Sequencing Services
6.1.2 Increasing Collaborations
6.1.3 Increasing Awareness
6.2 Regulatory Analysis
6.2.1 Us
6.2.2 Europe
6.2.3 Japan
6.2.4 China
6.2.5 India
6.3 Strategic Benchmarking
6.3.1 Genotyping Market: Product Portfolio Analysis (Instruments & Kits)
6.3.2 Genotyping Market: Product Portfolio Analysis (Bioinformatics)

7 Genotyping Market, By Product & Service
7.1 Introduction
7.2 Reagents & Kits
7.2.1 Reagents & Kits Accounted for the Largest Share of the Genotyping Market in 2017
7.3 Genotyping Services
7.3.1 Increasing Demand for Sequencing and Genotyping Services From Hospitals, Small- and Medium-Sized Research Centers, and Pharmaceutical Companies to Drive the Growth of This Segment
7.4 Instruments
7.4.1 Sequencers & Amplifiers
7.4.1.1 Sequencers & Amplifiers Segment to Register the Highest Growth Rate in the Genotyping Instruments Market During the Forecast Period
7.4.2 Analyzers
7.4.2.1 Growing Automation and Advancements in Analyzers With High-Throughput Capacities are the Major Factors Driving Market Growth
7.5 Bioinformatics
7.5.1 Software
7.5.1.1 Software Segment Accounted for the Largest Share of the Genotyping Bioinformatics Market in 2017
7.5.2 Services
7.5.2.1 Shortage of Skilled Bioinformatics Professionals and the Growing Applications of Bioinformatics in Various Industries are the Major Factors Driving the Growth of This Segment

8 Genotyping Market, By Technology
8.1 Introduction
8.2 Polymerase Chain Reaction
8.2.1 Real-Time PCR
8.2.1.1 Real-Time PCR Dominated the PCR Market in 2017, Primarily Due to the Growing Adoption of These Instruments Among Researchers and Healthcare Professionals
8.2.2 Digital PCR
8.2.2.1 The High Cost of Dpcr Instruments to Restrain the Growth of This Market
8.3 Microarrays
8.3.1 Increasing Demand for Personalized Medicine and Continuous Launch of Custom Arrays By Leading Players to Drive Market Growth
8.4 Sequencing
8.4.1 Next-Generation Sequencing
8.4.1.1 NGS to Witness the Highest Growth Rate in the Sequencing Market During the Forecast Period
8.4.2 Pyrosequencing
8.4.2.1 Growing Demand for Pyrosequencing By Pharmaceutical and Biotechnology Companies to Drive the Adoption of This Technology Segment
8.4.3 Sanger Sequencing
8.4.3.1 Increasing Use of This Technology in Small-Scale Experiments is the Major Factor Driving Market Growth
8.5 Capillary Electrophoresis
8.5.1 Amplified Fragment Length Polymorphism
8.5.1.1 Aflp Technique to Witness the Highest Growth Rate in the Capillary Electrophoresis Market During the Forecast Period
8.5.2 Restriction Fragment Length Polymorphism
8.5.2.1 Increasing Demand for Rflp From Forensics, Agricultural Institutions, and Pharmaceutical and Biotechnology Companies-Major Factor Driving Market Growth
8.5.3 Single-Strand Conformation Polymorphism
8.5.3.1 Increasing Applications of Sscp in Virology are Expected to Play A Key Role in the Growth of the Sscp Market
8.6 Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry
8.6.1 Increasing Applications of This Technique in Clinical Diagnostics and Pharmacogenomics to Drive Market Growth
8.7 Other Technologies

9 Genotyping Market, By Application
9.1 Introduction
9.2 Pharmacogenomics
9.2.1 Pharmacogenomics Segment Accounted for the Largest Share of the Genotyping Market in 2017
9.3 Diagnostics & Personalized Medicine
9.3.1 Technological Advancements and Increasing Potential of Developing Diagnostics Tests Through Rapid Genotyping Techniques are the Key Factors Driving the Growth of This Application Segment
9.4 Animal Genetics
9.4.1 Lower Adoption of Genotyping Technologies in Animal Breeding Programs in Developing Countries to Restrain the Growth of This Segment
9.5 Agricultural Biotechnology
9.5.1 Increasing Number of Research Laboratories and Greenhouses Using Plant Genotyping and Continuous Product Innovations and New Product Launches are Driving the Growth of the Agricultural Biotechnology Segment
9.6 Other Applications

10 Genotyping Market, By End User
10.1 Introduction
10.2 Pharmaceutical & Biopharmaceutical Companies
10.2.1 Pharmaceutical & Biopharmaceutical Companies to Register the Highest Growth During the Forecast Period
10.3 Diagnostic & Research Laboratories
10.3.1 Growing Preference for Personalized Medicine and Increasing Research Focused on Personalized Diagnosis are the Key Factors Driving Market Growth
10.4 Academic Institutes
10.4.1 Increasing Research Activities for Drug Discovery and Rising Industry-Academia Collaborations for Drug Development are the Key Factors Driving Market Growth
10.5 Other End Users

11 Genotyping Market, By Region
11.1 Introduction
11.2 North America
11.2.1 US
11.2.1.1 US Dominated the North American Genotyping Market in 2018; This Trend to Continue During the Forecast Period
11.2.2 Canada
11.2.2.1 Increasing Incidence of Genetic Diseases & the Availability of A Wide Range of Genotyping Products to Drive Market Growth in Canada
11.3 Europe
11.3.1 Germany
11.3.1.1 Germany Accounted for the Largest Share of the European Genotyping Market in 2017
11.3.2 France
11.3.2.1 Increasing Incidence of Genetic Disorders & Growing Public-Private Investments are Driving the Growth of the Genotyping Market in France
11.3.3 UK
11.3.3.1 UK to Witness the Highest Growth in the European Genotyping Market During the Forecast Period
11.3.4 Italy
11.3.4.1 Presence of A Well-Developed Healthcare System and Rapid Growth in the Geriatric Population are Key Factors Driving Market Growth in Italy
11.3.5 Spain
11.3.5.1 The Lingering Effect of Economic Downturns Will Continue to Affect Healthcare in Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 China
11.4.1.1 Infrastructural Improvements in China's Healthcare System Have Boosted Treatment Rates and Care Delivery
11.4.2 Japan
11.4.2.1 Strong Base of Pharmaceutical Activity Will Contribute to the Use of Genotyping
11.4.3 India
11.4.3.1 Growth of the Pharmaceutical Industry has Highlighted the Need for Better Infrastructure in India
11.4.4 Rest of APAC
11.5 Latin America
11.6 Middle East and Africa

12 Competitive Landscape
12.1 Overview
12.2 Product Portfolio Matrix
12.3 Market Share Analysis
12.4 Competitive Situations and Trends

13 Company Profiles
13.1 Illumina, Inc.
13.2 Thermo Fisher Scientific, Inc.
13.3 Roche Diagnostics Limited
13.4 Qiagen N.V.
13.5 Danaher Corporation
13.6 Agilent Technologies, Inc.
13.7 Fluidigm Corporation
13.8 GE Healthcare
13.9 Genewiz, Inc.
13.10 Integrated Dna Technologies, Inc. (A Subsidiary of Danaher Corporation)
13.11 Perkinelmer, Inc.
13.12 Bio-Rad Laboratories, Inc.
13.13 Eurofins Scientific
13.14 Pacific Biosciences of California, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/tnzx9q/global_genotyping?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets